An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope

被引:181
作者
Seifert, U
Marañón, C
Shmueli, A
Desoutter, JF
Wesoloski, L
Janek, K
Henklein, P
Diescher, S
Andrieu, M
de la Salle, H
Weinschenk, T
Schild, H
Laderach, D
Galy, A
Haas, G
Kloetzel, PM
Reiss, Y
Hosmalin, A
机构
[1] Humboldt Univ, Fac Med, Inst Biochem Charite, D-10117 Berlin, Germany
[2] Inst Cochin, Dept Immunol, INSERM,U567,CNRS,UMR 8104, IFR 116, F-75014 Paris, France
[3] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel
[4] Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany
[5] EFS Alsace, INSERM, EP9908, F-676065 Strasbourg, France
[6] Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany
[7] Genethon, F-91002 Evry, France
[8] Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France
关键词
D O I
10.1038/ni905
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most of the peptides presented by major histocompatibility complex (MHC) class I molecules require processing by proteasomes. Tripeptidyl peptidase II (TPPII), an aminopeptidase with endoproteolytic activity, may also have a role in antigen processing. Here, we analyzed the processing and presentation of the immunodominant human immunodeficiency virus epitope HIV-Nef(73-82) in human dendritic cells. We found that inhibition of proteasome activity did not impair Nef(73-82) epitope presentation. In contrast, specific inhibition of TPPII led to a reduction of Nef(73-82) epitope presentation. We propose that TPPII can act in combination with or independent of the proteasome system and can generate epitopes that evade generation by the proteasome-system.
引用
收藏
页码:375 / 379
页数:5
相关论文
共 37 条
[1]   Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells [J].
Andrieu, M ;
Desoutter, JF ;
Loing, E ;
Gaston, J ;
Hanau, D ;
Guillet, JG ;
Hosmalin, A .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1564-1570
[2]  
BALOW RM, 1986, J BIOL CHEM, V261, P2409
[3]   26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate [J].
Ben-Shahar, S ;
Komlosh, A ;
Nadav, E ;
Shaked, I ;
Ziv, T ;
Admon, A ;
DeMartino, GN ;
Reiss, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) :21963-21972
[4]  
Benham AM, 1998, J IMMUNOL, V161, P83
[5]   Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase [J].
Beninga, J ;
Rock, KL ;
Goldberg, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :18734-18742
[6]   Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes:: Wealth of HLA-binding motifs and sensitivity to proteasome degradation [J].
Choppin, J ;
Cohen, W ;
Bianco, A ;
Briand, JP ;
Connan, F ;
Dalod, M ;
Guillet, JG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6164-6169
[7]   IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN [J].
CULMANNPENCIOLELLI, B ;
LAMHAMEDICHERRADI, S ;
COUILLIN, I ;
GUEGAN, N ;
LEVY, JP ;
GUILLET, JG ;
GOMARD, E .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7336-7343
[8]   HOMOZYGOUS HUMAN TAP PEPTIDE TRANSPORTER MUTATION IN HLA CLASS-I DEFICIENCY [J].
DELASALLE, H ;
HANAU, D ;
FRICKER, D ;
URLACHER, A ;
KELLY, A ;
SALAMERO, J ;
POWIS, SH ;
DONATO, L ;
BAUSINGER, H ;
LAFORET, M ;
JERAS, M ;
SPEHNER, D ;
BIEBER, T ;
FALKENRODT, A ;
CAZENAVE, JP ;
TROWSDALE, J ;
TONGIO, MM .
SCIENCE, 1994, 265 (5169) :237-241
[9]   PEPTIDE MOTIFS OF HLA-A1, HLA-A11, HLA-A31, AND HLA-A33 MOLECULES [J].
FALK, K ;
ROTZSCHKE, O ;
TAKIGUCHI, M ;
GRAHOVAC, B ;
GNAU, V ;
STEVANOVIC, S ;
JUNG, G ;
RAMMENSEE, HG .
IMMUNOGENETICS, 1994, 40 (03) :238-241
[10]   Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum [J].
Fruci, D ;
Niedermann, G ;
Butler, RH ;
van Endert, PM .
IMMUNITY, 2001, 15 (03) :467-476